Teligent Inc Quick Ratio (TLGT) starting from the second quarter 2021 to second quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Teligent Inc   (NASDAQ: TLGT)

Teligent Inc 's Quick Ratio

TLGT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2021, Quick Ratio deteriorated to 1.8 below Teligent Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 477 other companies have achieved higher Quick Ratio than Teligent Inc in second quarter 2021. While Quick Ratio total ranking in the second quarter 2021 has deteriorated compared to the prior quarter from 1910 to 2047.

Explain Quick Ratio?
How much Cash & cash equivalents TLGT´s has?
What are TLGT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TLGT Quick Ratio (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1		 (Dec 31 2020)
Q4		 (Sep 30 2020)
Q3		 (Jun 30 2020)
Q2
Y / Y Current Liabilities Change -47.06 % -25.51 % 53.08 % -47.08 % -17.18 %
Y / Y Cash & cash equivalent Change 286.7 % 148.95 % -61.66 % 44.6 % 41.98 %
Quick Ratio MRQ 1.8 2.03 0.23 0.52 0.25
TLGT's Total Ranking # 2047 # 1910 # 3516 # 3465 # 3229
Seq. Current Liabilities Change -6.88 % -46.91 % 37.36 % -22.05 % 31.03 %
Seq. Cash & cash equivalent Change -17.59 % 361.72 % -38.69 % 65.75 % -46.94 %



Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 478
Healthcare Sector # 851
Overall Market # 2047


Quick Ratio Statistics
High Average Low
22.69 3.57 0.14
(Dec 31 2014)   (Jun 30 2019)




Financial Statements
Teligent Inc 's Current Liabilities $ 13 Millions Visit TLGT's Balance sheet
Teligent Inc 's Cash & cash equivalent $ 23 Millions Visit TLGT's Balance sheet
Source of TLGT's Sales Visit TLGT's Sales by Geography


Cumulative Teligent Inc 's Quick Ratio

TLGT's Quick Ratio for the trailling 12 Months

TLGT Quick Ratio

 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months		 (Dec 31 2020)
12 Months		 (Sep 30 2020)
12 Months		 (Jun 30 2020)
12 Months
Y / Y Current Liabilities TTM Growth -25.09 % -17.48 % -21.81 % -37.57 % -26.67 %
Y / Y Cash & cash equivalent TTM Growth 68.12 % 31.01 % -0.64 % 56.28 % 10.15 %
Quick Ratio TTM 0.94 0.6 0.38 0.55 0.42
Total Ranking TTM # 4741 # 4760 # 4816 # 2243 # 4701
Seq. Current Liabilities TTM Growth -13.77 % -5.39 % 11.45 % -17.62 % -5.01 %
Seq. Cash & cash equivalent TTM Growth 34.27 % 50.51 % -22.72 % 7.65 % 4.63 %

Quick ratio ranking by company, industry and sector >> Back to TLGT Financial Strength Comparisons >> Go to Compare TLGT Quick Ratio to its Competitors

On the trailing twelve months basis TLGT Cash & cash equivalent more than doubled by 286.7 % in Q2 2021 year on year, while Current Liabilities decreased to $13 millions, this led to increase in in Teligent Inc 's Quick Ratio to 0.94, Quick Ratio remained below TLGT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 516 other companies have achieved higher Quick Ratio than Teligent Inc . While Quick Ratio overall ranking has improved so far to 4741, from total ranking during the twelve months ending first quarter 2021 at 4760.

Explain Quick Ratio?
How much Cash & cash equivalents TLGT´s has?
What are TLGT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 517
Healthcare Sector # 1004
Within the Market # 4741


trailing twelve months Quick Ratio Statistics
High Average Low
9.2 2.5 0.21
(June 30. 2015)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Jun 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
China Health Industries Holdings Inc   4.87 $ 44.347  Millions$ 9.113  Millions
Aeon Biopharma inc   4.79 $ 0.989  Millions$ 0.206  Millions
Vbi Vaccines Inc  4.73 $ 135.027  Millions$ 28.533  Millions
Summit Therapeutics Inc   4.72 $ 142.735  Millions$ 30.219  Millions
Panbela Therapeutics Inc   4.60 $ 6.405  Millions$ 1.393  Millions
Xeris Biopharma Holdings Inc   4.57 $ 115.980  Millions$ 25.364  Millions
Cti Biopharma Corp   4.55 $ 71.881  Millions$ 15.789  Millions
Therapeuticsmd Inc   4.54 $ 111.424  Millions$ 24.565  Millions
Biovie Inc   4.53 $ 4.512  Millions$ 0.996  Millions
Molecular Templates Inc   4.47 $ 197.602  Millions$ 44.236  Millions
Ascendis Pharma A  4.46 $ 500.819  Millions$ 112.399  Millions
Avadel Pharmaceuticals Plc  4.44 $ 70.046  Millions$ 15.786  Millions
Cypherpunk Technologies Inc   4.44 $ 35.734  Millions$ 8.056  Millions
Cue Biopharma Inc   4.43 $ 73.920  Millions$ 16.673  Millions
Cohbar Inc   4.41 $ 13.824  Millions$ 3.134  Millions
Harmony Biosciences Holdings inc   4.36 $ 159.686  Millions$ 36.595  Millions
Zymeworks Inc   4.33 $ 359.811  Millions$ 83.005  Millions
Zosano Pharma Corporation  4.33 $ 22.058  Millions$ 5.098  Millions
Stablecoin Development Corporation  4.31 $ 10.294  Millions$ 2.389  Millions
Chimerix Inc   4.28 $ 106.584  Millions$ 24.922  Millions
Scisparc Ltd  4.24 $ 7.590  Millions$ 1.791  Millions
Karyopharm Therapeutics Inc   4.22 $ 236.652  Millions$ 56.044  Millions
Adamas Pharmaceuticals Inc  4.19 $ 91.370  Millions$ 21.824  Millions
Regulus Therapeutics Inc   4.16 $ 41.440  Millions$ 9.968  Millions
Ac Immune Sa  4.11 $ 89.893  Millions$ 21.896  Millions
Pharming Group N v   4.10 $ 191.924  Millions$ 46.771  Millions
Quoin Pharmaceuticals Ltd   4.10 $ 10.156  Millions$ 2.476  Millions
Quantum Biopharma Ltd   4.05 $ 35.260  Millions$ 8.701  Millions
Arbutus Biopharma Corp  4.04 $ 30.960  Millions$ 7.665  Millions
Precigen Inc   3.99 $ 115.106  Millions$ 28.869  Millions

Date modified: 2026-09-08T15:10:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.